1. |
Asadi-Pooya AA, Brigo F, Lattanzi S, et al. Adult epilepsy. Lancet, 2023, 402(10399): 412-424.
|
2. |
Zhu H, Deng X, Feng L, et al. Efficacy comparison of oxcarbazepine and levetiracetam monotherapy among patients with newly diagnosed focal epilepsy in China: a multicenter, open-label, randomized study. CNS Neurosci Ther, 2022(7): 1072-1080.
|
3. |
Kanner AM, Bicchi MM. Antiseizure medications for adults with epilepsy: a review. JAMA, 2022, 327(13): 1269-1281.
|
4. |
Yamamoto T, Gil-Nagel A, Wheless JW, et al. Perampanel monotherapy for the treatment of epilepsy: clinical trial and real-world evidence. Epilepsy Behav, 2022, 136: 108885.
|
5. |
卫材 (中国) 药业有限公司. 吡仑帕奈药品说明书. 2021.
|
6. |
Potschka H, Trinka E. Perampanel: Does it have broad-spectrum potential? Epilepsia, 2019, 60(Suppl 1): 22-36.
|
7. |
张凯月, 郑昭时, 王涵等. 吡仑帕奈治疗成人癫痫的临床实践. 癫痫杂志, 2023, 9(5): 369-374.
|
8. |
Olaciregui-Dague K, Weinhold L, Hoppe C, et al. Anti-seizure efficacy and retention rate of carbamazepine is highly variable in randomized controlled trials: a meta-analysis. Epilepsia Open, 2022, 7(4): 556-569.
|
9. |
Depondt C, Van Paesschen W, van Rijckevorsel K, et al. Brivaracetam retention rate and seizure outcomes in patients with drug-resistant focal epilepsy included in the medical need program in belgium: a real-world, multicenter, chart review. Drugs Real World Outcomes, 2021, 8(3): 407-415.
|
10. |
叶敬花, 田小琴, 操德智, 等. 癫痫患儿复诊保留率真实世界数据分析. 癫痫与神经电生理学杂志, 2022, 31(1): 29-33.
|
11. |
Yi JQ, Huang S, Wu MJ, et al. Comparison of the effectiveness and safety of perampanel and oxcarbazepine as monotherapy in children and adolescents with newly diagnosed focal epilepsy. Front Pharmacol, 2023, 14: 1189058.
|
12. |
Basheikh M, Sadler RM. Retention rate and efficacy of perampanel with a slow titration schedule in adults. Can J Neurol Sci, 2021, 48(1): 105-111.
|
13. |
Li D, Huang S, Wang X, et al. Efficacy and adverse reactions of perampanel in the treatment of epilepsy in children. Front Neurol, 2022, 13: 924057.
|
14. |
Kharel S, Ojha R, Khanal S. Levetiracetam versus Oxcarbazepine as monotherapy in newly diagnosed focal epilepsy: a systematic review and meta-analysis. Brain Behav, 2022, 12(11): e2779.
|
15. |
裴紫娟, 王博文, 笱玉兰. 吡仑帕奈单药治疗成人局灶性癫痫的临床疗效及安全性评价. 实用药物与临床, 2023, 26(2): 132-135.
|
16. |
陈李兰, 王健彪, 周逸能, 等. 吡仑帕奈单药治疗儿童局灶性癫痫的临床疗效研究. 癫痫杂志, 2023, 9(3): 192-194.
|
17. |
徐郑嫣然, 徐莎, 郑园园, 等. 吡仑帕奈单药治疗局灶性癫痫患者的疗效及安全性研究. 癫痫与神经电生理学杂志, 2023, 32(3): 146-151.
|